High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients

Programmed death ligand 1 (PD-L1) expression is a predictive biomarker of the success of PD-1/PD-L1 inhibitor therapy for patients with advanced non-small cell lung cancer (NSCLC) but its role as a prognostic marker for early-stage resectable NSCLC remains unclear. We studied gene expression levels...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Genes (Basel)
Main Authors: Ludovini, Vienna, Bianconi, Fortunato, Siggillino, Annamaria, Vannucci, Jacopo, Baglivo, Sara, Berti, Valeria, Tofanetti, Francesca Romana, Reda, Maria Sole, Bellezza, Guido, Mandarano, Martina, Belladonna, Maria Laura, Metro, Giulio, Chiari, Rita, Sidoni, Angelo, Puma, Francesco, Minotti, Vincenzo, Roila, Fausto
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI 2021
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7918978/
https://ncbi.nlm.nih.gov/pubmed/33671892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12020273
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים